Search results for abx831128

Etaracizumab, Abbexa, abx831128

Etaracizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ITGAV/ITGB3, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.